As part of its assessment of the growth of private markets, the corporate regulator asked academics for their definitive take ...
Patient enrollment and site activation continues to progress in the Phase 1b PIONEER trial evaluating pociredir in patients with SCD. Fulcrum has enrolled 10 patients in the 12 mg dose cohort, and ...
Castellum, Inc. Announces Its GTMR Subsidiary Has Been Selected as a SCI MAC Vendor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback